Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells. - Wikidata - wikimedia - TriplyDB

Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells.

Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells.

http://www.wikidata.org/entity/Q35162222

about

Silaffins in Silica Biomineralization and Biomimetic Silica Precipitation Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility Nanoparticles for imaging and treating brain cancer Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Spatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles.VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.A reversible light-operated nanovalve on mesoporous silica nanoparticles.Targeted fluorescent magnetic nanoparticles for imaging of human breast cancer Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups.Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates.Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo.Nanoparticle-dendrimer hybrid nanocapsules for therapeutic delivery.Nanoparticle mediated non-covalent drug delivery Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles.Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.Smart Mesoporous Nanomaterials for Antitumor Therapy.Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.Molecular and supramolecular switches on mesoporous silica nanoparticles.Targeting Innate Immunity with dsRNA-Conjugated Mesoporous Silica Nanoparticles Promotes Antitumor Effects on Breast Cancer Cells.Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo.Biofabricated nanoparticle coating for liver-cell targeting.A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery.A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.LHRH-PE40 fusion protein tethered silica nanorattles for imaging-guided tumor-specific drug delivery and bimodal therapy.Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.Near-infrared-controlled, targeted hydrophobic drug-delivery system for synergistic cancer therapy.Correlation between Membrane Partitioning and Functional Activity in a Single Lipid Vesicle Assay Establishes Design Guidelines for Antiviral Peptides.Highly luminescent and photostable core-shell dye nanoparticles for high efficiency bioimaging.Bis-clickable Mesoporous Silica Nanoparticles: Straightforward Preparation of Light-Actuated Nanomachines for Controlled Drug Delivery with Active Targeting.A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions.

P2860

Q26795747-C3018D74-2D65-4987-BB03-CF30601798BB Q28384598-C26F9497-CAAF-4856-8BF3-3562187B48AE Q28394053-2090E775-8186-4269-9406-6E1BD3B57484 Q31065446-1D1EB7AD-F5BD-4992-9792-1C404617949A Q33594253-7FC4E825-958E-49B6-BF9E-CDB278F93E46 Q34674541-914F7425-1CD4-4AF1-BF52-8B3E394B9CAE Q35009134-B2A40924-6AAD-4613-BBB4-0DF9ED0975FC Q35016938-B1B1A48F-748B-4BD9-A44B-B6B9C3F896FB Q36103833-D9F58D06-CD46-4256-BBC9-9780D0D1F9D8 Q36161045-770F5AEF-1DBA-4CAF-BB53-5FD67FC8E03F Q36328315-77F0EBAE-C1D8-423E-9C4B-531AE7E1DD84 Q36511906-B62CAAB9-9354-4D55-9014-5427B637E903 Q36562731-53228A6B-F71F-426C-A885-5F61009239F3 Q36749553-931F2A1D-ABBC-44B3-AADF-BB42833C7BDE Q37013390-4DD33722-3598-447D-A986-E55AA6D31F10 Q37104463-39FAFA3B-D529-4826-BDC7-B60D6C8A3938 Q37134029-01F3DF51-F957-4CA1-A339-072A78B3A341 Q37157022-3D3A665C-FE92-4A0B-B9FC-5F00AD6A82B0 Q37327759-FA2F1944-76D5-4F59-BDB4-A40D0176DB40 Q37624164-2BE06874-2F2D-4869-8B86-8EA5385FDAA5 Q37638621-616C5D13-C692-4B2A-835A-CC81AB68881E Q37989408-16098586-C9EF-4855-84F1-57FDC8F17882 Q38002853-17475EB6-A643-45E2-A81C-622360C466D3 Q38154210-58C2636F-FEE5-4B8E-A398-C66C14153CC6 Q38271137-060D3BDB-D6E0-4A67-80D2-6D1CCBD22AD4 Q38437008-D311F6A0-8E88-4C43-B685-79140BE5172B Q38814030-AB4CB4FF-0D3E-4442-8C3D-81ED88B0F96F Q38827516-B79196AB-562D-4FC6-9C32-284EB5E6D5B5 Q38857018-614ED5F3-48C0-485D-9257-E01C832AF64E Q38857226-F0D15448-A1C4-4C55-B621-B1B9309C18A9 Q38874416-A91FD4EF-5C4F-4DDB-BCCB-14E476559E55 Q38958959-DC5985DE-D33E-4CA4-A05B-555616F50937 Q39084260-CC98EC04-4F8F-45B4-9CB0-A507AE321DC5 Q39121585-32CB3303-F74B-490A-8490-CE9B38C9A9AA Q39123634-54B4D2AA-D54E-4D22-AF06-1F7EC4B8376C Q39402544-3C7239C2-15D0-4210-AB93-0ECA215CDD27 Q42174162-C18F5D3C-F933-409D-B75A-BF3D85C03CD0 Q46189126-C1831511-5B5F-4EA1-8319-3EE08715889A Q46417451-BF8450C1-3085-478C-8C71-5EBDF5BF30F9 Q47101332-F582E3AF-4139-4935-800C-02D83D907280

P2860

Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells.

http://www.wikidata.org/entity/Q35162222

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Synthesis of biomolecule-modif ...... drug delivery to cancer cells.

@ast

Synthesis of biomolecule-modif ...... drug delivery to cancer cells.

@en

type

label

Synthesis of biomolecule-modif ...... drug delivery to cancer cells.

@ast

Synthesis of biomolecule-modif ...... drug delivery to cancer cells.

@en

prefLabel

Synthesis of biomolecule-modif ...... drug delivery to cancer cells.

@ast

Synthesis of biomolecule-modif ...... drug delivery to cancer cells.

@en

P1433

Q35162222-8C329C3E-84A8-49EC-86FC-DD98F104165F

P1476

Q35162222-A88F801F-CA2A-4953-B145-AD9CD38C1A19

P2093

Q35162222-30C2C50D-1B2D-456A-AC2B-27246B8AEF09

Q35162222-382B6360-641F-434D-8B10-C34169A7F914

Q35162222-431F8B89-3940-49AF-954B-332D47102C41

Q35162222-7E7FC1FD-8A0B-454D-8FD4-30E245048E6B

Q35162222-828BFFC6-3AE7-4F1B-8A94-6220F27E7547

Q35162222-8391A7F2-BC0B-4BDB-B96F-9D38ED606F92

Q35162222-B00D09CD-BAA2-4602-AC03-80D2142D5199

Q35162222-E8515BD3-56FD-439F-8E60-A2B19EE8DEE7

P2860

Q35162222-01819561-CF84-475A-AEE1-CF67CE229C05

Q35162222-0B462C47-B253-46A7-9BDF-EA3D66D581EF

Q35162222-0EBA2327-DD15-465F-ADE1-529A3492D052

Q35162222-0ED04016-5B8A-48C3-9620-F183849671EC

Q35162222-230A516A-9192-41F2-B9C7-85FA43FB124A

Q35162222-296394C2-6B27-40F7-BD62-43C0F50ED6A2

Q35162222-3034DCE7-5FA2-4C78-822C-160657214CE8

Q35162222-341D5D12-4564-41ED-9A13-8E4C4DA123D6

Q35162222-35C87C48-9E2A-4A6E-8EB5-A7DE6A3EE6C0

Q35162222-35D23500-1968-4366-BD4D-39AD019D46A1

P304

Q35162222-411C4BD7-CA8B-4A07-9E07-B22B9497FF5D

P31

Q35162222-98369C1D-E35A-4265-837E-A04469DFB8A2

P356

Q35162222-0FF66375-099A-416B-8AE2-554E99E57065

P433

Q35162222-2456FCD5-2429-4D70-A287-4C0B91141702

P478

Q35162222-962C8D7A-C5E0-4228-B6AD-A3AD303B12EF

P50

Q35162222-DD645AE1-EC83-4C3A-84DD-8BA289F6F942

P577

Q35162222-03578EAC-187B-4C84-AA44-0BABF6140EF8

P5875

Q35162222-84E32D40-2CAC-4BAF-B00B-36875D1714A3

P698

Q35162222-8BB7AAE1-8510-4E6D-8B56-2F2F93377B39

P921

Q35162222-53D80F32-5E03-49EA-A68D-B746DFA472B4

Q35162222-5DE3404A-9B28-4C46-8023-32F7656720C0

Q35162222-B9F68AAE-8298-44EC-9940-992AADD60D6A

P932

Q35162222-3349E15B-2BDF-4EC6-B04A-2F45E550D94F

P356

P1433

P1476

Synthesis of biomolecule-modif ...... drug delivery to cancer cells.

@en

P2093

Chris Gothard

http://www.w3.org/2001/XMLSchema#string

Courtney R Thomas

http://www.w3.org/2001/XMLSchema#string

Daniel P Ferris

http://www.w3.org/2001/XMLSchema#string

Fuyuhiko Tamanoi

http://www.w3.org/2001/XMLSchema#string

Jeffrey I Zink

http://www.w3.org/2001/XMLSchema#string

Jie Lu

http://www.w3.org/2001/XMLSchema#string

John-Carl Olsen

http://www.w3.org/2001/XMLSchema#string

Rolando Yanes

http://www.w3.org/2001/XMLSchema#string

P2860

The emerging nanomedicine landscape

Nanoscale clustering of RGD peptides at surfaces using Comb polymers. 1. Synthesis and characterization of Comb thin films.

Encapsulation and controlled release of a hydrophobic drug using a novel nanoparticle-forming hyperbranched polyester.

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery.

Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging.

Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

Ligand binding to integrins.

Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.

RGD modified polymers: biomaterials for stimulated cell adhesion and beyond.

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities.

P304

1816-1826

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SMLL.201002300

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Fraser Stoddart

P577

2011-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51148964

http://www.w3.org/2001/XMLSchema#string

P698

21595023

http://www.w3.org/2001/XMLSchema#string

P921

P932

3155389

http://www.w3.org/2001/XMLSchema#string